文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

筛查频率与自主呼吸试验技术:一项随机临床试验

Frequency of Screening and Spontaneous Breathing Trial Techniques: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2024-01-01
一句话结论在机械通气≥24小时的成人中,每日一次与更频繁筛查、压力支持与T管自主呼吸试验均未改变成功拔管时间;但更频繁筛查联合压力支持自主呼吸试验延长了成功拔管时间。

该2×2析因随机临床试验纳入北美23个ICU中接受有创机械通气至少24小时、能触发呼吸机且吸入氧浓度≤70%、呼气末正压≤12 cm H2O的成人797例,比较每日一次筛查与更频繁筛查、压力支持自主呼吸试验与T管自主呼吸试验对成功拔管时间的影响。结果显示,筛查频率(HR 0.88,95%CI 0.76-1.03,P=.12)与自主呼吸试验技术(HR 1.06,95%CI 0.91-1.23,P=.45)均未显著改变成功拔管时间。但发现筛查频率与自主呼吸试验技术存在意外交互作用:更频繁筛查联合压力支持自主呼吸试验较每日一次筛查联合压力支持自主呼吸试验延长成功拔管时间(HR 0.70,95%CI 0.50-0.96,P=.02);每日一次筛查联合压力支持自主呼吸试验较T管自主呼吸试验未缩短成功拔管时间(HR 1.30,95%CI 0.98-1.70,P=.08)。

要点

  • 在机械通气≥24小时成人中,每日一次筛查与更频繁筛查的成功拔管时间无显著差异(HR 0.88,95%CI 0.76-1.03,P=.12)。
  • 压力支持自主呼吸试验与T管自主呼吸试验的成功拔管时间无显著差异(HR 1.06,95%CI 0.91-1.23,P=.45)。
  • 更频繁筛查联合压力支持自主呼吸试验较每日一次筛查联合压力支持自主呼吸试验延长成功拔管时间(HR 0.70,95%CI 0.50-0.96,P=.02)。
  • 每日一次筛查联合压力支持自主呼吸试验较T管自主呼吸试验未缩短成功拔管时间(HR 1.30,95%CI 0.98-1.70,P=.08)。
  • 四组中位成功拔管时间分别为:每日一次筛查+压力支持2.0天(95%CI 1.7-2.7)、每日一次筛查+T管3.1天(95%CI 2.7-4.8)、更频繁筛查+压力支持3.9天(95%CI 2.9-4.7)、更频繁筛查+T管2.9天(95%CI 2.0-3.1)。

适用人群与场景

  • 纳入:接受有创机械通气至少24小时的危重症成人,能够启动自主呼吸或触发呼吸机,吸入氧浓度≤70%且呼气末正压≤12 cm H2O。
  • 场景:北美23个重症监护病房,2018年1月至2022年2月招募,末次随访2022年10月18日。

处置流程与药物剂量

  • 方案化筛查(更频繁筛查 vs 每日一次)以确定患者最早符合接受压力支持或T管自主呼吸试验的标准。
  • 压力支持自主呼吸试验:压力支持水平>0-≤8 cm H2O,呼气末正压>0-≤5 cm H2O。
  • T管自主呼吸试验。
  • 自主呼吸试验持续30至120分钟。

研究设计与关键结果

  • 研究类型:2×2析因随机临床试验,纳入797例危重症成人,来自北美23个重症监护病房。
  • 分组:每日一次筛查+压力支持自主呼吸试验198例,每日一次筛查+T管自主呼吸试验204例,更频繁筛查+压力支持自主呼吸试验195例,更频繁筛查+T管自主呼吸试验200例。
  • 人群特征:平均年龄62.4岁(SD 18.4),男性472例(59.2%)。
  • 主要终点:筛查频率对成功拔管时间无显著差异(HR 0.88,95%CI 0.76-1.03,P=.12);自主呼吸试验技术对成功拔管时间无显著差异(HR 1.06,95%CI 0.91-1.23,P=.45)。
  • 中位成功拔管时间:每日一次筛查+压力支持自主呼吸试验2.0天(95%CI 1.7-2.7),每日一次筛查+T管自主呼吸试验3.1天(95%CI 2.7-4.8),更频繁筛查+压力支持自主呼吸试验3.9天(95%CI 2.9-4.7),更频繁筛查+T管自主呼吸试验2.9天(95%CI 2.0-3.1)。
  • 交互作用:筛查频率与自主呼吸试验技术存在意外交互作用,更频繁筛查(vs 每日一次筛查)联合压力支持自主呼吸试验延长成功拔管时间(HR 0.70,95%CI 0.50-0.96,P=.02);每日一次筛查联合压力支持自主呼吸试验(vs T管自主呼吸试验)未缩短成功拔管时间(HR 1.30,95%CI 0.98-1.70,P=.08)。

证据类型、等级与局限

  • 证据类型:随机临床试验(2×2析因设计)。
  • 试验注册:ClinicalTrials.gov标识NCT02399267和NCT02969226。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在符合纳入条件的机械通气≥24小时成人中,每日一次筛查与更频繁筛查、压力支持与T管自主呼吸试验对成功拔管时间无显著差异。
  • 更频繁筛查联合压力支持自主呼吸试验较每日一次筛查联合压力支持自主呼吸试验延长成功拔管时间,作者认为该意外交互作用需在临床决策中考虑。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The optimal screening frequency and spontaneous breathing trial (SBT) technique to liberate adults from ventilators are unknown.

OBJECTIVE: To compare the effects of screening frequency (once-daily screening vs more frequent screening) and SBT technique (pressure-supported SBT with a pressure support level that was >0-≤8 cm H2O and a positive end-expiratory pressure [PEEP] level that was >0-≤5 cm H2O vs T-piece SBT) on the time to successful extubation.

DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial with a 2 × 2 factorial design including critically ill adults who were receiving invasive mechanical ventilation for at least 24 hours, who were capable of initiating spontaneous breaths or triggering ventilators, and who were receiving a fractional concentration of inspired oxygen that was 70% or less and a PEEP level of 12 cm H2O or less. Recruitment was between January 2018 and February 2022 at 23 intensive care units in North America; last follow-up occurred October 18, 2022.

INTERVENTIONS: Participants were enrolled early to enable protocolized screening (more frequent vs once daily) to identify the earliest that patients met criteria to undergo pressure-supported or T-piece SBT lasting 30 to 120 minutes.

MAIN OUTCOME AND MEASURES: Time to successful extubation (time when unsupported, spontaneous breathing began and was sustained for ≥48 hours after extubation).

RESULTS: Of 797 patients (198 in the once-daily screening and pressure-supported SBT group, 204 in once-daily screening and T-piece SBT, 195 in more frequent screening and pressure-supported SBT, and 200 in more frequent screening and T-piece SBT), the mean age was 62.4 (SD, 18.4) years and 472 (59.2%) were men. There were no statistically significant differences by screening frequency (hazard ratio [HR], 0.88 [95% CI, 0.76-1.03]; P = .12) or by SBT technique (HR, 1.06 [95% CI, 0.91-1.23]; P = .45). The median time to successful extubation was 2.0 days (95% CI, 1.7-2.7) for once-daily screening and pressure-supported SBT, 3.1 days (95% CI, 2.7-4.8) for once-daily screening and T-piece SBT, 3.9 days (95% CI, 2.9-4.7) for more frequent screening and pressure-supported SBT, and 2.9 days (95% CI, 2.0-3.1) for more frequent screening and T-piece SBT. An unexpected interaction between screening frequency and SBT technique required pairwise contrasts that revealed more frequent screening (vs once-daily screening) and pressure-supported SBT increased the time to successful extubation (HR, 0.70 [95% CI, 0.50-0.96]; P = .02). Once-daily screening and pressure-supported SBT (vs T-piece SBT) did not reduce the time to successful extubation (HR, 1.30 [95% CI, 0.98-1.70]; P = .08).

CONCLUSIONS AND RELEVANCE: Among critically ill adults who received invasive mechanical ventilation for more than 24 hours, screening frequency (once-daily vs more frequent screening) and SBT technique (pressure-supported vs T-piece SBT) did not change the time to successful extubation. However, an unexpected and statistically significant interaction was identified; protocolized more frequent screening combined with pressure-supported SBTs increased the time to first successful extubation.

TRIAL REGISTRATION: ClinicalTrials.gov Identifiers: NCT02399267 and NCT02969226.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Burns KEA, Wong J, Rizvi L, et al. Frequency of Screening and Spontaneous Breathing Trial Techniques: A Randomized Clinical Trial. JAMA. 2024. PMID: 39382222. doi:10.1001/jama.2024.20631

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。